The study demonstrated the independent role of ER- with respect to mechanical loading and its effect on the chondrocyte phenotype (163)
2 Since it is non-peptide, orforglipron avoids GI degradation barriers that limit peptides, thereby enabling once-daily administration while maintaining efficacy on glucose control, body weight, and tolerability
Biomarkers for depression: recent insights, current challenges and future prospects
GLP-1 drugs present a historic opportunity to create value for people with obesity, their families, and the nation as long as society can effectively share them across the health care marketplace
Before starting semaglutide, it is important to discuss any current medications and medical conditions with your healthcare provider
Patients should also report burning associated with systemic symptoms such as nausea, vomiting, or abdominal pain, as these may represent gastrointestinal adverse effects of semaglutide rather than injection site reactions